Case reportLate cardiac perforation following transcatheter atrial septal defect closure
Section snippets
Comment
Postmarket surveillance of the clinical experience with the Amplatzer Septal Occluder, and other such devices continues. Device malposition, residual shunts, hemolysis, embolization into the right ventricle and pulmonary arterial tree, peripheral embolization into the leg, partial occlusion of the superior vena cava, damage to the mitral or tricuspid valves, and sudden death after implantation of an Amplatzer device from 1 to 18 months later have been reported 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11,
References (13)
- et al.
Immediate and six-month results of the profile of the Amplatzer septal occluder as assessed by transesophageal echocardiography
Am J Cardiol
(2001) - et al.
Surgical Management of Complications After Transcatheter Closure of an Atrial Septal Defect or Patent Foramen Ovale
J Thorac Cardiovasc Surg
(2000) - et al.
Comparison of results and complications of surgical and Amplatzer device closure of atrial septal defects
J Thorac Cardiovasc Surg
(1999) - et al.
Early and late complications associated with transcatheter occlusion of secundum atrial septal defect
J Am Coll Cardiol
(2002) Later results of closure of secundum atrial septal defects in children
Am J Cardiol
(1973)- et al.
Perforation of the aorta after percutaneous closure of an atrial septal defect with an Amplatz prosthesis, presenting with acute severe hemolysis
Arch Mal Coeur Vaiss
(2002)
Cited by (71)
State-of-the-Art Atrial Septal Defect Closure Devices for Congenital Heart
2019, Interventional Cardiology ClinicsDelayed perforation of a transcatheter patent foramen ovale occluder 10 years after implantation
2015, Annals of Thoracic SurgeryCitation Excerpt :These adverse events may appear early and also very late after implantation of the device. Early device displacement, embolization, residual shunt, and thrombus formation may require surgical removal [2]. A late adverse event such as cardiac perforation is a rare and life-threatening condition, with an incidence of 0.1% [3] to 0.9% [4].
Large Amplatzer atrial septal occluder in growing children: An echographic study
2015, Cardiology in the YoungSurgery for complications of trans-catheter closure of atrial septal defects: a multi-institutional study from the European Congenital Heart Surgeons Association
2010, European Journal of Cardio-thoracic SurgeryAtrial Septal Defect, Partial Anomalous Pulmonary Venous Connection, and Scimitar Syndrome
2023, Pediatric Cardiac Surgery, Fifth EditionEarly and Mid-Term Follow-Up Results After Transcatheter Closure of Secundum Atrial Septal Defect
2022, Turkish Archives of Pediatrics